Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk - sprookjes - yvandenbroek - TriplyDB

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

http://www.wikidata.org/entity/Q24654734

about

CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1 Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status CCR5 deficiency increases risk of symptomatic West Nile virus infection Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine CCR5 haplotypes and mother-to-child HIV transmission in Malawi.Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32 A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants CR1 Knops blood group alleles are not associated with severe malaria in the Gambia Human PTCHD3 nulls: rare copy number and sequence variants suggest a non-essential gene.Experimental aspects of copy number variant assays at CCL3L1 A whole genome association study of mother-to-child transmission of HIV in Malawi.Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes HIV-transmission-related risk behavior in HIV+ African American men: Exploring biological, psychological, cognitive, and social factors.Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.Chemokine receptor CCR5 Delta 32 genetic analysis using multiple specimen types and the NucliSens Basic Kit CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.Ending the epidemic of heterosexual HIV transmission among African Americans.Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors.Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection

P2860

Q19028101-40CCB6B5-CD7D-4C4F-A996-543A4F356144 Q21245210-C760F908-0BF9-49FE-A107-4BEED9CCCAAD Q22066229-664DCAAB-7639-45B7-993D-B1D5EFD05904 Q24324020-AB867B95-1C1B-48E6-A2D8-940586833C9A Q24538942-94C9144A-632A-4D80-804B-727A676E9967 Q24608200-4F4D8D61-700D-4AFB-95E3-A1523A6AF314 Q24672737-A4AA739C-3338-44B9-AE78-C96BD02E6050 Q24677652-C39ACD26-B409-4B30-97ED-7738D906CF56 Q24800209-CAD5AEF1-D1C0-4971-BEB1-519D586D59E6 Q27468933-404F8CCE-BF3A-40DF-9927-B04C7586882A Q27487937-972E08C7-4072-4DAC-9F9C-EB1A3E9176D4 Q28481687-59865DA7-E8FE-4DA7-92CB-D4AF185568A7 Q28539889-3DA77175-201F-46F9-B10C-60DD26C96358 Q28591681-E67E87EE-894B-4A4B-ABC1-245AF6145DBE Q30448634-88C54F7B-1AD6-45D1-9020-91919DEB7163 Q30760711-9D78E5CD-2E3C-4451-87AC-C08BC6FC1775 Q33296998-81439C3D-86C2-4FE5-A83D-98E25A210DC2 Q33383193-3EBB72B5-767B-4B68-9D1C-AE84DBDEE6C2 Q33532625-CF7B67C1-A0DA-4549-A1A6-9BC0D332BA63 Q33615123-DCBDBAB3-B023-4994-8664-6D47660A9BCE Q33654027-1443A9B5-7D52-4774-84E8-106AD2BE67EB Q33785490-27569A4F-56C2-40C1-B27D-D128824CA29B Q33785711-E35E3F84-76B3-4EA2-B033-B64BD03E3E27 Q33785913-117B93F8-715C-446E-A04D-6B2DEFD8DABD Q33825328-DD2586A9-7DFE-4F9D-A652-4CB9EEB72F1E Q33849061-748C05B9-1D86-4BA9-A76E-BDB1E444A9BD Q33856496-1666B352-BF14-4807-AFEB-170E10D5D925 Q33864642-4552CDBA-56CA-4D1E-BDA0-99B44D66F42A Q33865715-A140F8D0-DC5B-4618-ABE5-5F3C6900AF2C Q33876727-FCBFCD6C-3EEE-4CBA-9CF4-C99614479241 Q33902346-F8E9CF2E-CFE2-4AAA-A040-F658EE413246 Q33997498-87174A4F-42D0-4265-BB8A-B752E8835EED Q33999482-C1368866-38C0-4ED7-8A0D-D066FB66F543 Q34118698-5627EA09-49F1-45B1-977E-4A8798176577 Q34169244-7B2FB6E0-CEC8-48DC-AD1A-7E1FC0FA6F19 Q34205575-E4730D7B-631C-4AA0-B30E-1A37F97F0535 Q34289973-930F8D57-B48B-4C52-B9AD-3532784F7DA7 Q34357979-325DD0E7-2432-4567-9BDC-1C084BBBCFD9 Q34362854-A3829BD4-2B18-4044-95D1-8F1C53DB047A Q34404437-F8F18947-8ABF-48BB-96B9-A1C276674429

P2860

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

http://www.wikidata.org/entity/Q24654734

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@ast

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@en

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@nl

type

label

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@ast

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@en

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@nl

prefLabel

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@ast

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@en

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@nl

P1433

Q24654734-8F7A1833-80FC-4C8A-8700-C2E7F8AAB421

P1476

Q24654734-D18EBC95-CC80-4A22-A8A7-358C473CC7AE

P2093

Q24654734-0E89C9FF-DE83-458C-ACF4-8F6D8950CDFF

Q24654734-17E28C92-BB12-482C-986E-E13619CB180D

Q24654734-32B5F1E9-36D2-47C6-9B88-9758B1EF7AEA

Q24654734-3A95C690-034B-4CDE-B48E-3EA74F7B247B

Q24654734-3B5D6FBE-9136-424D-A6BC-FFD26708E73E

Q24654734-548A058D-C18E-4AD3-80A9-7B356D0CC7DC

Q24654734-5804EB37-FE57-4395-A9CE-B34C9405FB18

Q24654734-68327AB1-F31A-490B-903B-07521E5444DC

Q24654734-7FB0A1C0-2C9E-4895-9B2B-6B22501ADDDB

Q24654734-8F5259F5-902C-4D1D-9E18-97F100A4E5F3

P2860

Q24654734-077E4833-ADDF-4D0A-9CB8-6F7D926B29EE

Q24654734-135D39DB-E5AC-470D-83FE-D51BC4DEEF41

Q24654734-15754E1A-034C-4AA5-A3E6-D749026B8928

Q24654734-177F1792-9999-4BF3-A321-1536A6D7C293

Q24654734-1BA76068-7F85-449B-A308-472F86D3A95F

Q24654734-1C01D816-36AC-46FD-AADD-943690DD4A1D

Q24654734-1E1A25BD-BDCF-423B-8D1B-F4798DD6EF5F

Q24654734-22FA2601-B760-4596-B0F4-1C1CEB097D80

Q24654734-28CC69CF-9260-4E9E-B0BE-770D713376BD

Q24654734-3F617855-8252-42EE-9830-0DDAE22A38E1

P2888

Q24654734-4CD86AF4-DA67-4CFB-8669-ED3073E63FA2

P304

Q24654734-028F1ED8-CBE2-43A6-91A9-2B9265638299

P31

Q24654734-60B90F76-7FB3-42B8-8FC6-7017B6AC81F9

P3181

Q24654734-46FC7CB7-0CBB-4E2C-84C5-3831D69E8FB0

P356

Q24654734-ADEBE8FD-9A1E-40F7-848E-6075608A94F8

P407

Q24654734-D6C9B16E-2393-45CC-A185-3044624F3C2D

P433

Q24654734-1CA3CE53-0741-4922-A5D8-D9B854C21196

P478

Q24654734-133687C1-16C8-4EC9-B84D-2F74A9FD59A7

P50

Q24654734-FF7F5394-8B2A-4706-A145-C7AC3F3AEA98

P577

Q24654734-294CB5C3-DFC9-46FB-A922-863C17DB6800

P6179

Q24654734-3BD2C0BA-E6C7-47D1-B55B-53FF89150B3C

P698

Q24654734-F0A0BA4A-1C93-47E6-8928-2614CA778E97

P932

Q24654734-EB21025D-ADB3-46E7-911F-4814045D58F3

P3181

P356

P1433

Molecular Medicine

P1476

Inherited resistance to HIV-1 ...... ackground, and quantified risk

@en

P2093

A Buckler-White

http://www.w3.org/2001/XMLSchema#string

A Rubbert

http://www.w3.org/2001/XMLSchema#string

C Combadiere

http://www.w3.org/2001/XMLSchema#string

D Weissman

http://www.w3.org/2001/XMLSchema#string

E A Berger

http://www.w3.org/2001/XMLSchema#string

G Alkhatib

http://www.w3.org/2001/XMLSchema#string

G Lam

http://www.w3.org/2001/XMLSchema#string

J Hunter

http://www.w3.org/2001/XMLSchema#string

J Kubofcik

http://www.w3.org/2001/XMLSchema#string

J V Giorgi

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor

Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES

Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

P2888

P304

23-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2602754

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/BF03401665

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083082328

http://www.w3.org/2001/XMLSchema#string

P698

9132277

http://www.w3.org/2001/XMLSchema#string

P932

2230106

http://www.w3.org/2001/XMLSchema#string